Sjögren's disease: open trials in Bulgaria

• NCT07737743

  A Phase 2a/b Study to Assess the Efficacy, Safety and Tolerability of DDY391 in Participants With Sjögren's Disease

  Trial Treatment · Phase 2 · Novartis Pharmaceuticals

  University Multiprofile Hospital For Active Treatment Pulmed Ltd., Plovdiv · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia

  Registry updated 2026-10-28

• NCT07404865

  Phase 3 Study of Telitacicept in Active Primary Sjögren's Disease

  Trial Treatment · Phase 3 · Vor Biopharma

  Medical Centre Epiona, Plovdiv · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia · University Hospital Lozenetz, Sofia

  Registry updated 2026-10-19

• NCT07760818

  A Study to Assess Efficacy and Safety of Efgartigimod in Adults With Sjogren's Disease-associated Sensorimotor Polyneuropathy or Sensory Polyneuropathy (SERENITY)

  Trial Treatment · Phase 2 · argenx

  Medical center NeoGeneX Ltd., Sofia · Medical Center MedSpace OOD, Sofia · Medical Center Polyclinic Bulgaria Ltd., Sofia · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia

  Registry updated 2026-08-12

• NCT06991114

  AlloNK®, an Allogeneic Non-genetically Modified, Cord Blood-derived NK Cell Therapy, in Combination With Rituximab, Studied in Relapsing Forms of B-cell Dependent Rheumatologic Diseases.

  Trial Treatment · Phase 2 · Artiva Biotherapeutics, Inc.

  University Multiprofile Hospital For Active Treatment Saint Georgi EAD, Plovdiv · University Multiprofile Hospital For Active Treatment St. Ivan Rilski EAD, Sofia

  Registry updated 2026-07-31

All Sjögren's disease trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error